Clinical Trial

Effect of Probiotics on Relapsing-Remitting Multiple Sclerosis

Study acronym: PRO-RRMS
Completed
View on ClinicalTrials.gov →
Summary
This study aimed to assess the effect of probiotic supplementation on fatigue, quality of life, disability, depression and inflammatory markers in patients with relapsing-remitting multiple sclerosis (RRMS). Patients were randomized to receive probiotics plus standard therapy The study sought to determine whether modulation of gut microbiota could provide additional clinical and immunological benefits in RRMS management.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-08.
Trial Details
NCT Number NCT07346924
Lead Sponsor Cairo University
Conditions Multiple Sclerosis (MS) Relapsing Remitting
Enrollment 60 participants
Start Date 2024-01-01
Primary Completion 2024-09-01 (estimated)
Study Completion 2025-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-08